Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Bortezomib-AFT
Active Ingredient: Bortezomib 3.5mg
Dosage Form: Powder for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Qilu Pharmaceutical (Hainan) Co Limited, Haikou, China
   
Product: Brimonidine Indoco
Active Ingredient: Brimonidine tartrate 2mg/mL equivalent to brimonidine 1.3mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Miro Healthcare Limited
Manufacturer: Indoco Remedies Limited, Verna, India
   
Product: Ibuprofen Soft Gel Caps (General sale)
Active Ingredient: Ibuprofen 200mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: XL Laboratories Pvt. Limited, Neemrana, India
   
Product: Ibuprofen Soft Gel Caps (Pharmacy only)
Active Ingredient: Ibuprofen 200mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: AFT Pharmaceuticals Limted
Manufacturer: XL Laboratories Pvt. Limited, Neemrana, India
   
Product: Iluvien
Active Ingredient: Fluocinolone acetonide 190mcg
Dosage Form: Intraocular implant
New Zealand Sponsor: Specialised Therapeutics Limited
Manufacturer: Alliance Medical Products Inc, California, United States of America
   
Product: MenQuadfi
Active Ingredients: Neisseria meningitidis Group A polysaccharide 10mcg
Neisseria meningitidis Group C polysaccharide 10mcg
Neisseria meningitidis Group W135 polysaccharide 10mcg
Neisseria meningitidis Group Y polysaccharide 10mcg
Dosage Form: Solution for injection
New Zealand Sponsor: Sanofi-Aventis New Zealand Limited
Manufacturer: Sanofi Pasteur Inc, Pennsylvania, United States of America


Dated this 8th day of June 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).